It is interesting to consider what may happen if the animal program is taken up by Vet Major soon. I have thought that the main aim of this program is to generate cash to push us forward to a human cancer program. Now we have Covid as well.
A dream situation would be a largish upfront from Vet Major, less need to raise cash for the next stage of the company, including fast-tracking Covid.
Glad I kept these shares (there were times!!!)
Clinical Trials, page-246
-
- There are more pages in this discussion • 64 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.5¢ |
Change
-0.020(8.89%) |
Mkt cap ! $81.16M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 21.0¢ | 19.5¢ | $331.9K | 1.617M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 440882 | 20.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 12736 | 3 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| PAA (ASX) Chart |